Listed

BioCardia, Inc.: Form 10-Q for the period ended Sep 30, 2013

Filed with the SEC on Nov 1, 2013 and accepted by EDGAR at Nov 1, 2013, 10:04 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Operating income3 months2013-07-01 to 2013-09-30$26.0kus-gaap:OperatingIncomeLoss
Operating income9 months2013-01-01 to 2013-09-30$6.0kus-gaap:OperatingIncomeLoss
Income tax3 months2013-07-01 to 2013-09-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax9 months2013-01-01 to 2013-09-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-07-01 to 2013-09-30$30.0kus-gaap:NetIncomeLoss
Net income9 months2013-01-01 to 2013-09-30$14.0kus-gaap:NetIncomeLoss
Diluted EPS3 months2013-07-01 to 2013-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2013-01-01 to 2013-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted shares (weighted)3 months2013-07-01 to 2013-09-30230,293,141 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2013-01-01 to 2013-09-30230,293,141 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2013-01-01 to 2013-09-30−$5.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2013-09-30$13.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Total assetsAt period end2013-09-30$13.3mus-gaap:Assets
Total liabilitiesAt period end2013-09-30$3.0kus-gaap:Liabilities
Shareholders' equityAt period end2013-09-30$13.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001136261-13-000486. Last ingested by Listed: Nov 13, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.